TY  - JOUR
AU  - Martinón-Torres, Federico
AU  - Carmona Martinez, Alfonso
AU  - Simkó, Róbert
AU  - Infante Marquez, Pilar
AU  - Arimany, Josep-Lluis
AU  - Gimenez-Sanchez, Francisco
AU  - Couceiro Gianzo, José Antonio
AU  - Kovács, Éva
AU  - Rojo, Pablo
AU  - Wang, Huajun
AU  - Bhusal, Chiranjiwi
AU  - Toneatto, Daniela
PY  - 2017
DO  - 10.1016/j.jinf.2017.12.005
UR  - http://hdl.handle.net/10668/11922
T2  - The Journal of infection
AB  - This phase IIIb, open-label, multicentre, extension study (NCT01894919) evaluated long-term antibody persistence and booster responses in participants who received a reduced 2 + 1 or licensed 3 + 1 meningococcal serogroup B vaccine (4CMenB)-schedule...
LA  - en
KW  - 2 + 1 schedule
KW  - Antibody persistence
KW  - Booster response
KW  - Children
KW  - Infants
KW  - Meningococcal B vaccine
KW  - Open-label randomised clinical trial
KW  - Safety
KW  - Antibodies, Bacterial
KW  - Child
KW  - Child, Preschool
KW  - Female
KW  - Humans
KW  - Immunization Schedule
KW  - Immunization, Secondary
KW  - Immunogenicity, Vaccine
KW  - Male
KW  - Meningococcal Vaccines
KW  - Neisseria meningitidis, Serogroup B
KW  - Time Factors
TI  - Antibody persistence and booster responses 24-36 months after different 4CMenB vaccination schedules in infants and children: A randomised trial.
TY  - research article
VL  - 76
ER  -